Physician profile
Erin R Anderson
NPI 1811220601
$1,086.43
in general payments reported to CMS, 2019-2025
17 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.57 · 2020: $171 · 2021: $265 · 2022: $136 · 2023: $114 · 2024: $176 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435 · Gift: $1.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.98 |
| Gift | $1.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $260.39 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Oyster Point Pharma, INC. | $175.19 | 2022-2025 | Tyrvaya |
| Allergan, INC. | $114.21 | 2020-2022 | |
| Johnson & Johnson Vision Care, INC. | $88.33 | 2021-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $73.48 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $67.46 | 2020-2022 | |
| Bausch & Lomb Americas INC. | $50.21 | 2023-2025 | Infuse, Xiidra, Miebo |
| Eyevance Pharmaceuticals LLC | $45.34 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $36.91 | 2020-2021 | |
| Aerie Pharmaceuticals, INC. | $36.63 | 2021 | |
| Biotissue Holdings INC. | $34.23 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $24.31 | 2020-2021 | |
| Shire North American Group INC | $20.99 | 2019 | |
| Dompe US, INC. | $19.78 | 2021 | |
| Astellas Pharma US INC | $13.34 | 2023 | Izervay |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $12.95 | 2019 | |
| Thea Pharma INC. | $12.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.